J&J Wins Jury Verdict Vs. Boston Scientific In Patent Suit Over Drug-Coated Stent

Law360, New York (March 26, 2005, 12:00 AM EST) -- Johnson & Johnson is emerging triumphantly from its patent litigation against its rivals in the highly lucrative market for drug-eluting stents, winning a second major victory this month in a jury verdict that could lead to hundreds of millions of dollars in damages.

On Thursday, a federal jury in Delaware ruled for J&J in the retrial of a four-year-old lawsuit against Boston Scientific over a patent for a drug-eluting coronary-artery stent.

The jury, in the U.S. District Court for the District of Delaware, found that a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.